Find Research Projects

Search results

• A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With ? 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN+) After Neoadjuvant Chemotherapy

  Niravath, P. A., Bernicker, E. H., Chang, J. C., Heyne, K., Morgan, P. B. & Singh, M.

  Project: Clinical Trial

• Lung COPD Progressive

  Chang, J. C., Bernicker, E. H., Chen, S., El-Zein, R., Heyne, K., Huang, H. J., Niravath, P. A. & Zhang, J.

  Project: Clinical Trial

• SWOG 1007

  Niravath, P. A., Chang, J. C. & Singh, M.

  Project: Clinical Trial

• 68Ga-PSMA 11

  Miles, B. J., Boone, T. B., Chiang, S., Fujita, M., Gupta, N., Satkunasivam, R. & Yu, M.

  Project: Clinical Trial

• DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane

  Niravath, P. A., Chang, J. C., Heyne, K. & Singh, M.

  Project: Clinical Trial

• HMDHVC Clinical CMR Database

  Shah, D. J., El-Tallawi, C., Faza, N., Graviss, E. A., Lin, C. H. & Nabi, F.

  Project: Clinical Trial

• Brain Metastases Registry

  Rostomily, R. C., Baskin, D. S., Bernicker, E. H., Britz, G. W., Butler, E. B., Chang, J. C., Farach, A. M., Fung, S. H. & Teh, B. S.

  Project: Clinical Trial

• SH-PORTICO

  Kleiman, N., Faza, N., Goel, S., Lawrie, G. M., Lin, C. H., Little, S. H. & Reardon, M. J.

  Project: Clinical Trial

• SH-The Intrepid TMVR Pilot Study

  Kleiman, N., Faza, N., Goel, S., Little, S. H. & Reardon, M. J.

  Project: Clinical Trial

• Neoadjuvant Combination Therapy of Lenvima® plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-Eligible Patients with Large Hepatocellular Carcinoma

  Abdelrahim, M., Connor, A. A., Ghobrial, R. M., Graviss, E. A., Heyne, K., Kodali, S., Moore, L. W., Singh, M. & Victor, III, D. W.

  Project: Clinical Trial

• A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab With Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

  Chang, J. C., Darcourt, J., Geyer, C. E. & Niravath, P. A.

  Project: Clinical Trial

• Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NRG-GY009)

  Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.

  Project: Clinical Trial

• A Randomized, Open-label, Phase II Study of Canakinumab or Pembrolizumab as Monotherapy or in Combination as Neoadjuvant Therapy in Subjects With Resectable Non-small Cell Lung Cancer (CANOPY-N)

  Bernicker, E. H., Barrios, R., Chan, E. Y., Chang, J. C., Heyne, K., Kim, M. P., Niravath, P. A., Singh, M. & Zhang, J.

  Project: Clinical Trial

• A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

  Project: Clinical Trial

• Use of thermal imaging to detect deep tissue pressure injury in the perioperative setting

  Project: Clinical Trial

• POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in STANDARD RISK PATIENTS with SIGNIFICANT CAROTID ARTERY DISEASE (The ROADSTER 3 Study)

  Project: Clinical Trial

• Natera - MOTR

  Huang, H. J., Goodarzi, A. & Yau, S. W.

  Project: Clinical Trial

• A Prospective, Global, Multicenter, Single Arm Post-Approval Study Investigating the Clinical Use and Safety of the Lutonix® Drug Coated Balloon PTA Catheter for the Treatment of Dysfunctional AV Fistulae

  Peden, E. K., Le, L. & Rahimi, M.

  Project: Clinical Trial

• Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso (BREEZE)

  Sahay, S. & Safdar, Z.

  Project: Clinical Trial

• AOCT-A Phase 2b, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study with Open-Label Extension to Evaluate the Safety and Efficacy of ST266 Eye Drops in the Treatment of Persistent Corneal Epithelial Defects

  Pandit, R. & Queen, J. H.

  Project: Clinical Trial

• A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA) - Pregnancy Reporting of Male Study Subject's Partner

  Youssef, J. G.

  Project: Clinical Trial

• A Randomized, Double-Blind, Placebo-controlled, Single-ascending Dose Study to Assess the Safety and Tolerability of JK07 in Subjects with Heart Failure with Preserved Ejection Fraction (HFpEF)

  Kassi, M., Bhimaraj, A., Guha, A., Hussain, I., Kim, J. H. & Yousefzai, R.

  Project: Clinical Trial

• A MULTICENTER, PHASE 2, OPEN-LABEL STUDY OF INTRATUMORAL CMP-001 IN COMBINATION WITH INTRAVENOUS PEMBROLIZUMAB IN SUBJECTS WITH RECURRENT OR METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA

  Zhang, J., Bernicker, E. H. & Heyne, K.

  Project: Clinical Trial

• AOCT - Athena Study

  Friedman, J. D., Albright, S. & Ellsworth, IV, W. A.

  Project: Clinical Trial

• Digital Characterization of Post-Operative Air Leaks

  Kim, M. P., Chan, E. Y. & Chihara, R.

  Project: Clinical Trial

• LTI-302 INSPIRE EXTENSION STUDY

  Sahay, S. & Safdar, Z.

  Project: Clinical Trial

• DecisionDx-Melanoma Impact on Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes (DECIDE)

  Allenson, K. C. & Esnaola, N. F.

  Project: Clinical Trial

• Phase 3, Randomized, Open-Label Study to Compare Ociperlimab (BGB-A1217) Plus Tislelizumab (BGB-A317) Plus Concurrent Chemoradiotherapy (cCRT) Followed by Ociperlimab Plus Tislelizumab or Tislelizumab Plus cCRT Followed by Tislelizumab Versus cCRT Followed by Durvalumab in Previously Untreated, Locally Advanced, Unresectable Non-Small Cell Lung Cancer

  Bernicker, E. H., Singh, M. & Zhang, J.

  Project: Clinical Trial

• Genomic Translation for ALS Clinical Care

  Appel, S. H., Greene, E. P., Shroff, S. & Thonhoff, J. R.

  Project: Clinical Trial

• An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

  Shroff, S., Appel, S. H., Greene, E. P., Liao, B. & Thonhoff, J. R.

  Project: Clinical Trial

• GOG-0225

  Kamat, A. A., Alaniz, A., Singh, M., Suri, A. & Zaid, T.

  Project: Clinical Trial

• SH-Low Risk Bicuspid

  Kleiman, N., Faza, N., Goel, S., Little, S. H., Mahmarian, J. J., Nabi, F. & Reardon, M. J.

  Project: Clinical Trial

• Lung Retrospective Protocol

  Chang, J. C., Bernicker, E. H., Heyne, K., Niravath, P. A. & Zhang, J.

  Project: Clinical Trial

• PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2

  Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A. & Singh, M.

  Project: Clinical Trial

• SH-Optimize IP-15-001

  Shah, A. R., Buergler, J. & Kleiman, N.

  Project: Clinical Trial

• MEDEOR - MDR-101-MLK

  Gaber, A. O., Farach, A. M., Knight, R. J., Saharia, A. & Yi, S.

  Project: Clinical Trial

• DS-8201a Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed

  Niravath, P. A., Chang, J. C., Heyne, K. & Singh, M.

  Project: Clinical Trial

• A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy

  Templeton, S., Arentz, C., Chang, J. C., Darcourt, J., Dubrovsky, E., Haque, W. M., Heyne, K., Morgan, P. B., Niravath, P. A. & Singh, M.

  Project: Clinical Trial

• Phase 3 Study of Sacituzumab Govitecan vs Physician's Choice in Subjects With Hormonal Receptor-Positive Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Who Have Failed at Least 2 Prior Chemotherapy Regimens

  Niravath, P. A., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Singh, M. & Zhang, J.

  Project: Clinical Trial

• SH-Medtronic TAVR in Low Risk Patients

  Kleiman, N., Faza, N., Goel, S., Lawrie, G. M., Lin, C. H., Little, S. H., Mahmarian, J. J. & Reardon, M. J.

  Project: Clinical Trial

• Phase II_PevonedistatVenetoclaxAzacitidine_AML_Pevonedistat-2002Takeda A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy

  Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.

  Project: Clinical Trial

• VAS-Zenith p-Branch Pivotal Study

  Lumsden, A. B. & Rahimi, M.

  Project: Clinical Trial

• Determining the sensitivity and specificity of a 2-question written questionnaire for psychosis in Lewy body diseases for both patients and patient?s caregiver

  Ondo, W. G. & Waln, O.

  Project: Clinical Trial

• FAME 3

  Shah, A. R., Buergler, J., Kleiman, N. & Reardon, M. J.

  Project: Clinical Trial

• Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

  Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.

  Project: Clinical Trial

• GORE® TAG® Thoracic Branch Endoprosthesis

  Chang, S., Lumsden, A. B., Peden, E. K., Rahimi, M. & Reardon, M. J.

  Project: Clinical Trial

• Open Label and Placebo-Controlled Assessment of Sublingual Apomorphine (Kynmobi) as Adjunct Therapy for Subjects with Refractory Restless Legs Syndrome

  Ondo, W. G. & Waln, O.

  Project: Clinical Trial

• ABSORB RCT

  Shah, A. R., Kleiman, N. & Lin, C. H.

  Project: Clinical Trial

• AC-058B201 Echocardiographic Ancillary Study

  Nagueh, S. & Chang, S.

  Project: Clinical Trial

• Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.

  Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.

  Project: Clinical Trial